are all glp-1 drugs injectable Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Oral GLP-1 Therapy: Pills vs

Average weight loss in clinical trials is approximately 5-6% of body weight

A third, recent study in JAMA Network Open , from August of 2025, analyzed data from 159,000 people with type 2 diabetes who took semaglutide or tirzepatide (Mounjaro, Zepbound)

Transient elastography in the diagnosis of pediatric non-alcoholic fatty liver disease and its subtypes

Similarly, large observational studies with robust methods for outcomes assessment (thyroid cancer and subtypes), analysis of confounders and comparisons between different agents in the GLP-1 RA class could help identify differences in associated risks for thyroid cancer